Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Salivary microbiota refers to the complex and diverse collection of microorganisms, including bacteria, fungi, viruses, and archaea, that inhabit the human oral cavity and are suspended in saliva. This ecosystem plays a fundamental role in maintaining both oral and systemic health by providing a protective barrier against pathogenic colonization, contributing to the initial digestion of carbohydrates, and modulating local immune responses (Kilian et al., 2016, British Dental Journal). Unlike traditional molecular targets such as single receptors or enzymes, the salivary microbiota is a community-level therapeutic target where the objective is often to restore ecological balance rather than total eradication (Belibasakis et al., 2019, Molecular Oral Microbiology). Dysbiosis of the salivary microbiota is significantly linked to local diseases like dental caries and periodontitis, as well as systemic conditions including cardiovascular disease, type 2 diabetes, and certain cancers through the systemic dissemination of oral pathogens and inflammatory mediators (Genco & Sanz, 2020, Journal of Clinical Periodontology). Therapeutic interventions include the use of antiseptic mouthwashes, targeted antibiotics, and probiotics designed to selectively suppress pathogens like Porphyromonas gingivalis or promote beneficial species (Caselli et al., 2020, Journal of Clinical Medicine). As a diagnostic and therapeutic target, the salivary microbiota offers a non-invasive window into the host's health status and a means to prevent systemic inflammation through oral health management (He et al., 2015, Postgraduate Medical Journal).
Broad-spectrum bacterial cell wall disruption, inhibition of bacterial protein synthesis, competitive exclusion by probiotic strains, and disruption of dental biofilm architecture.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salivary microbiota.